HIGHLIGHTS
- who: Yuki Katsuya et al. from the u2018Granda, Italy Sapienza University of Rome, Italy have published the article: Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma, in the Journal: (JOURNAL)
- what: The authors report the results of a comprehensive immunological evaluation of both the tissue and blood samples from the PRIMER study and identify several potential biomarkers for future evaluation. To note, the outcomes (long SD, irAE) used to categorize the patients in this manuscript were not the objectives of the PRIMER study nor known markers of a drug . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.